Gatehouse Bio logo

Gatehouse Bio

A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides

11 employees · est. 2020 · Natick, United States

VS
Odyssey Therapeutics logo

Odyssey Therapeutics

Building a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases

125 employees · est. 2021

Gatehouse Bio is the older company (2020 vs 2021); Odyssey Therapeutics is the larger of the two.

Side-by-Side Comparison

Gatehouse Bio Odyssey Therapeutics
Founded
2020 older 2021
Headquarters
Natick, United States Not tracked yet
Employees
11 125 larger
Industry
Biotechnology Biotechnology, Pharmaceutical
Funding Stage
Convertible Note IPO
Total Funding
$7.95M $1.07B
Funding Rounds
7 7
Services
Not tracked yet Drug Discovery, Therapeutic Development, Immunotherapy Research, Biologic Candidate Identification
Target Customers
Not tracked yet Patients with Autoimmune Diseases, Patients with Inflammatory Conditions, Healthcare Professionals, Biotechnology Researchers
Taxonomy
TechBio, Small RNA, SRNA, Oligonucleotides, RNA Therapeutics, In Silico, Digital Drug Design, Precision Medicines Novel Therapeutics, Cancer Treatment, Autoimmune Diseases, Precision Medicines, Drug Discovery, Immunomodulators, Oncology Medicines, Integrated Drug-hunting Engine, Clinical Development, Precision Medicine Development, Drug Hunting, Efficiency In Drug Development, Therapeutics Development
Website
gatehousebio.com odysseytx.com
Gatehouse Bio logo

About Gatehouse Bio

Gatehouse Bio is a groundbreaking TechBio company harnessing the power of artificial intelligence to decipher the complex realm of small RNAs (sRNAs) and craft precision oligonucleotides. Founded in 2018 and headquartered in the United States, the company is dedicated to decoding sRNA isoforms for t...

Odyssey Therapeutics logo

About Odyssey Therapeutics

Odyssey Therapeutics, founded in 2021, stands at the forefront of the intersection between biotechnology and pharmaceuticals. The company is committed to leveraging a machine learning-based platform to develop innovative therapeutics specifically targeting cancer and autoimmune diseases. With a focu...

We will tell you when either one moves

BounceWatch watches Gatehouse Bio and Odyssey Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Gatehouse Bio and Odyssey Therapeutics — by email.

Frequently Asked Questions

Gatehouse Bio — A TechBio company utilizing AI to decode the landscape of small RNAs (sRNAs) and design precision oligonucleotides. Odyssey Therapeutics — Building a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Gatehouse Bio has raised $7.95M while Odyssey Therapeutics has raised $1.07B.
Gatehouse Bio and Odyssey Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Gatehouse Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Gatehouse Bio on 12 Sep 2024, and Odyssey Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy